Kilitch Drugs(I)
₹359.25
+11.5 (3.31%)
28 April, 2024 12:00 BSE: 524500
NSE: KILITCHISIN: INE729D01010
Start SIP in Kilitch Drugs(I)
Start SIPKilitch Drugs(I) Performance
Day Range
- Low 341
- High 365
52 Week Range
- Low 165
- High 470
- Open Price352
- Previous Close348
- Volume13522
Kilitch Drugs(I) Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 30 | 32 | 31 | 43 |
| Operating Expenses Qtr Cr | 26 | 26 | 26 | 37 |
| Operating Profit Qtr Cr | 4 | 6 | 5 | 7 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 1 | 0 | 0 | 0 |
| Tax Qtr Cr | 1 | 2 | 1 | 2 |
| Net Profit Qtr Cr | 5 | 4 | 4 | 5 |
Kilitch Drugs(I) Technicals
EMA & SMA
Current Price
₹359.25
+11.5 (3.31%)
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹360.02
- 50 Day
- ₹369.66
- 100 Day
- ₹360.53
- 200 Day
- ₹322.10
- 20 Day
- ₹365.28
- 50 Day
- ₹374.76
- 100 Day
- ₹380.41
- 200 Day
- ₹308.96
Kilitch Drugs(I) Resistance and Support
PIVOT
₹354.95
| Resistance | |
|---|---|
| First Resistance | 369.40 |
| Second Resistance | 379.55 |
| Third Resistance | 394.00 |
| RSI | 47.40 |
| MFI | 34.14 |
| MACD Single Line | -6.82 |
| MACD | -7.13 |
| Support | |
|---|---|
| First Resistance | 344.80 |
| Second Resistance | 330.35 |
| Third Resistance | 320.20 |
Kilitch Drugs(I) Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 16,544 | 991,978 | 59.96 |
| Week | 9,718 | 619,937 | 63.79 |
| 1 Month | 8,661 | 549,684 | 63.47 |
| 6 Month | 22,086 | 1,795,139 | 81.28 |
Kilitch Drugs(I) Result Highlights
Kilitch Drugs(I) Synopsis
NSE-Medical-Diversified
Kilitch Drugs(I) is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 117.78 Cr. and Equity Capital is Rs. 15.58 Cr. for the Year ended 31/03/2023. Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718.| Market Cap | 578 |
| Sales | 136 |
| Shares in Float | 0.50 |
| No of funds | 2 |
| Yield | 0.51 |
| Book Value | 2.86 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | |
| Alpha | 0.22 |
| Beta | 0.86 |
Kilitch Drugs(I)
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jul-23 |
|---|---|---|---|---|
| Promoters | 69.23% | 69.23% | 69.23% | 69.23% |
| Mutual Funds | ||||
| Insurance Companies | ||||
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | ||||
| Individual Investors | 25.38% | 26.13% | 26.13% | 26.5% |
| Others | 5.39% | 4.64% | 4.64% | 4.27% |
Kilitch Drugs(I) Management
| Name | Designation |
|---|---|
| Mr. Mukund P Mehta | Managing Director |
| Mr. Bhavin Mukund Mehta | Whole Time Director |
| Mrs. Mira B Mehta | Whole Time Director |
| Mr. Hemang J Engineer | Independent Director |
| Mr. Venkita Subramanian Rajan | Independent Director |
| Prof. Vasudev Krishna Murti | Independent Director |
Kilitch Drugs(I) Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Kilitch Drugs(I) Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-02-08 | Quarterly Results | |
| 2023-11-09 | Quarterly Results | |
| 2023-08-11 | Quarterly Results | |
| 2023-07-22 | Others | To consider and approve conversion of warrants into the equity shares of the Company to the specified person only. per share(5%)Final Dividend |
| 2023-05-29 | Audited Results |
Kilitch Drugs(I) FAQs
What is Share Price of Kilitch Drugs(I) ?
Kilitch Drugs(I) share price is ₹359 As on 28 April, 2024 | 11:46
What is the Market Cap of Kilitch Drugs(I) ?
The Market Cap of Kilitch Drugs(I) is ₹577.8 Cr As on 28 April, 2024 | 11:46
What is the P/E ratio of Kilitch Drugs(I) ?
The P/E ratio of Kilitch Drugs(I) is 39.7 As on 28 April, 2024 | 11:46
What is the PB ratio of Kilitch Drugs(I) ?
The PB ratio of Kilitch Drugs(I) is 3.8 As on 28 April, 2024 | 11:46